Talis Biomedical Corp (TLIS PINK) stock market data APIs
$1.4118
0(0%)
as of June 30, 2025
Try our APIs with
free plan!
Talis Biomedical Corp Financial Data Overview
Price chart is built with
Anychart
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
Prev. Close
1.4118
Open
1.4118
High
1.4118
Low
1.4118
52 wk Range
1.04-1.75
Market Cap
2 716 K
Shares Outstanding
1 823 K
Revenue
408 K
EPS
-4.8556
Beta
1.303
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Talis Biomedical Corp data using free add-ons & libraries
Get Talis Biomedical Corp Fundamental Data
Talis Biomedical Corp Fundamental data includes:
- Net Revenue: 408 K
- EBITDA: -45 576 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-08-13
- EPS/Forecast: -5.91
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Talis Biomedical Corp News
New
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of ac...
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
Although speculative enterprises tend to draw in a loyal band of followers, certain circumstances call for decisive action, as these small-cap stocks to avoid in August confirms. Nobody wants to be th...
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
REDWOOD CITY, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of ac...
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of ac...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
